RosVivo Therapeutics
PrivateLast Round
Corporate Funding
May 26, 2021
Est. Valuation
$11M
Total Funding Raised
$5.5M
Company Overview
RosVivo Therapeutics is a biotechnology company that develops microRNA and small interfering-RNA (siRNA) therapies for the treatment of metabolic and gastrointestinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RosVivo Therapeutics Comparables
Compare RosVivo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resalis Therapeutics | 83% | |
| Canary Cure Therapeutics | 82% | |
| AptamiR Therapeutics | 81% |
RosVivo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 26, 2021 |
RosVivo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RosVivo Therapeutics's valuation, stock price, and market status.
Is RosVivo Therapeutics a public or private company?
RosVivo Therapeutics is a private company.
What is the current stock price of RosVivo Therapeutics?
RosVivo Therapeutics is a private company, so its shares have no public market price. Caplight tracks RosVivo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RosVivo Therapeutics worth (valuation)?
RosVivo Therapeutics's valuation is estimated at $11.0M based on funding round data.
Can I buy RosVivo Therapeutics stock?
RosVivo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RosVivo Therapeutics's last funding round?
RosVivo Therapeutics's most recent funding round was Corporate Funding on May 26, 2021.
Who are the main investors in RosVivo Therapeutics?
Investor information for RosVivo Therapeutics is not publicly disclosed.
Will RosVivo Therapeutics IPO soon?
No public IPO plans have been announced for RosVivo Therapeutics.
How can I track RosVivo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in RosVivo Therapeutics's shares on secondary markets.